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1. Introduction
  Neurological disorders primarily affect the elderly 
population. Alzheimer’s disease (AD), the most common 
neurodegenerative disorder is characterized clinically 
by progressive memory deficits and impaired cognitive 
function[1,2]. AD is estimated to account for between 50 and 
60% of dementia cases in persons over 65 years of age and 
according to the United Nations, the number of people 
suffering from age-related neurodegeneration, particularly 
from AD, will exponentially increase from 25.5 million in 
2000 to an estimated 114 million in 2050[3]. It is a major 
public health concern in developed countries due to the 
increasing number of sufferers, placing strains on caregivers 
as well as on financial resources[2]. 
  A deficiency in levels of the neurotransmitter 
acetylcholine (ACh) has been observed in the brains 
of AD patients, and inhibition of acetylcholinesterase 
(AChE), the key enzyme which hydrolyses ACh, is a major 
treatment option for AD[4]. Traditionally used plants have 
been shown to be good options in the search for AChE 
inhibitors. Galantamine, originally isolated from plants 
of the Amaryllidaceae family, has become an important 
treatment of AD[5]. The AChE inhibitory activity of this drug 
is the principal mode of action to provide symptomatic 
relief. Galantamine increases the availability of ACh in 
the cholinergic synapse by competitively inhibiting the 
enzyme responsible for its breakdown, AChE. The binding 
of galantamine to AChE slows down the catabolism of ACh 
and, as a consequence, ACh levels in the synaptic cleft are 
increased[6-9]. It is licensed in Europe for AD treatment 
and was well tolerated and significantly improved cognitive 
function when administered to AD patients in multi-center 
randomized-controlled trials[10]. To date, several plants 
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have been identified as containing acetylcholinesterase 
inhibitory (AChEI) activity[11].
  Reactive oxygen species (ROS) generated from activated 
neutrophils and macrophages have been reported to play 
an important role in the pathogenesis of various diseases, 
including neurodegenerative disorders, cancer and 
atherosclerosis[12,13]. Oxidative processes are among the 
pathological features associated with the central nervous 
system in AD. Oxidative stress causes cellular damage 
and subsequent cell death especially in organs such as 
the brain. The brain in particular is highly vulnerable to 
oxidative damage as it consumes about 20% of the body’s 
total oxygen, has a high content of polyunsaturated fatty 
acids and lower levels of endogenous antioxidant activity 
relative to other tissues[14-16]. The brain of patients suffering 
from AD is said to be under oxidative stress as a result of 
perturbed ionic calcium balances within their neurons and 
mitochondria[17,18]. Herbal products are reported to possess 
the ability to act as antioxidants, thereby reducing oxidative 
damage[19]. Among the natural phytochemicals identified 
from plants, flavonoids together with flavonols, and phenols 
represent important and interesting classes of biologically 
active compounds. Evidence suggests that these compounds 
are effective in the protection of various cell types from 
oxidative injury[20].
  The aim of the present study was to determine the AChEI 
and antioxidant activity of the ethyl acetate and methanol 
extracts of 12 plants, traditionally used in the treatment of 
neurological disorders.
2. Material and methods
2.1. Chemicals
  Acetylthiocholine iodide (ATCI), acetylcholinesterase 
(AChE) type VI-S, from electric eel, 5,5´-dithiobis 
[2-nitrobenzoic acid] (DTNB), galanthamine, 1,1-
Diphenyl-2-picrylhydrazyl (DPPH), 2,2´-azinobis-3-
ethylbenzothiazoline-6-sulfonic acid (ABTS) and trolox 
were purchased from Sigma. Methanol and all other organic 
solvents (analytical grade) were purchased from Merck.
2.2. Plant collection and extract preparation
  Specimens investigated in this study were identified 
and voucher specimens deposited at the South African 
National Biodiversity Institute (SANBI), Tshwane. The plant 
samples were cut into small pieces and air-dried at room 
temperature. Dried material was ground to a fine powder 
and stored at ambient temperature till use. Six grams of 
the powdered plant material was extracted with 60 mL of 
either methanol or ethyl acetate for 24 h while shaking. The 
extracts were filtered, concentrated using a rotary vacuum 
evaporator and then further dried in vacuo at ambient 
temperature for 24 h. All extracts were stored at -20 ℃ prior 
to analysis. The residues were redissolved in either MeOH or 
ethyl acetate to the desired test concentrations.
2.3. Micro-plate assay for inhibition of acetylcholinesterase
  Inhibition of acetylcholinesterase activity was determined 
using Ellman’s colorimetric method[21] as modified by 
Eldeen et al[22]. Into a 96-well plate was placed: 25 毺L of 15 
mmol/L ATCI in water, 125 毺L of 3 mmol/L DTNB in Buffer 
A (50 mmol/L Tris-HCl, pH 8, containing 0.1 mol/
L NaCl and 0.02 mol/L MgCl2.6H2O), 50 毺L of Buffer 
B (50 mmol/L, pH 8, containing 0.1 % bovine serum 
albumin) and 25 毺L of plant extract (0.007 mg/mL, 0.016 mg/mL, 
0.031 mg/mL, 0.063 mg/mL or 0.125 mg/mL). Absorbance was 
determined spectrophotometrically (Labsystems Multiscan 
EX type 355 plate reader) at 405 nm at 45 s intervals, three 
times consecutively. Thereafter, AChE (0.2 U/mL) was 
added to the wells and the absorbance measured five times 
consecutively every 45 s. Galantamine served as the positive 
control. Any increase in absorbance due to the spontaneous 
hydrolysis of the substrate was corrected by subtracting the 
absorbance before adding the enzyme from the absorbance 
after adding the enzyme. The percentage inhibition was 
calculated using the equation:
  Inhibition (%) = 1 – (Asample/Acontrol) × 100  
  Where Asample is the absorbance of the sample extracts and 
Acontrol is the absorbance of the blank [methanol/ethyl acetate 
in 50 mmol/L Tris-HCl, (pH 8)]. Extract concentration 
providing 50% inhibition (IC50) was obtained by plotting the 
percentage inhibition against extract concentration.
2.4. Determination of total phenolics
  Total phenolic content was determined using the modified 
Folin-Ciocalteu method of Wolfe et al[23]. The extract (1 mg/mL) 
was mixed with 5 mL Folin-Ciocalteu reagent (diluted with 
water 1:10 v/v) and 4 mL (75 g/L) sodium carbonate. The 
mixture was vortexed for 15 s and allowed to stand for 30 min 
at 40 曟 for color development. Absorbance was measured at 
765 nm using a Hewlett Packard UV-VIS spectrophotometer. 
Total phenolic content is expressed as mg/g gallic acid 
equivalent and was determined using the equation based 
on the calibration curve: Y = 6.993X + 0.037, where X is the 
absorbance and Y is the gallic acid equivalent (mg/g).
2.5. Determination of total flavonoids
  Total flavonoid content was determined using the method 
of Ordonez et al[24]. A volume of  0.5 mL of 2% AlCl3 ethanol 
solution was added to 0.5 mL of sample solution (1 mg/
mL). After one hour at room temperature, the absorbance 
was measured at 420 nm using a Hewlett Packard UV-
VIS spectrophotometer. A yellow color is indicative of 
the presence of flavonoids. Total flavonoid content was 
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calculated as quercetin equivalent (mg/g), using the 
equation based on the calibration curve: Y = 0.025X, where X 
is the absorbance and Y is the quercetin equivalent (mg/g).
2.6. Determination of total flavonols
  Total flavonol content was assessed using the method of 
Kumaran and Karunakaran[25]. To 2 mL of sample (1 mg/mL), 
2 mL of 2% AlCl3 ethanol and 3 mL (50 g/L) sodium acetate 
solution were added. The samples were incubated for 2.5 h 
at 20 曟 after which absorbance was determined at 440 nm. 
Total flavonoid content was calculated using the equation 
based on the calibration curve: Y = 0.0255X, where X was the 
absorbance and Y is the quercetin equivalent (mg/g).
2.7. Antioxidant activity
2.7.1. DPPH radical scavenging activity
  The effect of the extracts on DPPH radical was estimated 
using the method of Liyana-Pathirana and Shahidi[26], with 
minor modifications. A solution of 0.135 mmol/L DPPH in 
methanol was prepared and 185 毺L of this solution was 
mixed with 15 毺L of varying concentrations of the extract 
(0.007 mg/mL, 0.016 mg/mL, 0.031 mg/mL, 0.063 mg/mL or 
0.125 mg/mL), in a 96-well plate. The reaction mixture was 
vortexed and left in the dark for 30 min (room temperature). 
The absorbance of the mixture was determined at 570 nm 
using a microplate reader. Trolox was used as the reference 
antioxidant compound. The ability to scavenge the DPPH 
radical was calculated using the equation:
  DPPH radical scavenging activity (%) = 
  [(Acontrol – Asample)/Acontrol] 伊 100
  Where Acontrol is the absorbance of DPPH radical + methanol 
and Asample is the absorbance of DPPH radical + sample 
extract/standard. The extract concentration providing 
50% inhibition (IC50) was obtained by plotting inhibition 
percentage versus extract concentration.
2.7.2. ABTS radical scavenging activity
  The method of Re et al[27] was adopted for the ABTS assay. 
The stock solution which was allowed to stand in the dark 
for 16 h at room temperature contained equal volumes of 7 
mmol/L ABTS salt and 2.4 mmol/L potassium persulfate. The 
resultant ABTS*+ solution was diluted with methanol until an 
absorbance of 0.706 依 0.001 at 734 nm was obtained. Varying 
concentrations (0.007 mg/mL, 0.016 mg/mL, 0.031 mg/mL, 
0.063 mg/mL or 0.125 mg/mL) of the extract were allowed to 
react with 2 mL of the ABTS*+ solution and the absorbance 
readings were recorded at 734 nm. The ABTS*+ scavenging 
capacity of the extract was compared with that of trolox and 
the percentage inhibition calculated as:
  ABTS radical scavenging activity (%) =
  [(Acontrol - Asample)/Acontrol] 伊 100
where Acontrol is the absorbance of ABTS radical + methanol 
and Asample is the absorbance of ABTS radical + sample 
extract/standard. The extract concentration providing 
50% inhibition (IC50) was obtained by plotting inhibition 
percentage versus extract concentration.
2.8. Statistical analysis
 All determinations were carried out on three occasions 
in triplicate. The results are reported as mean 依 standard 
deviation (S.D.). Calculation of IC50 values was done using 
GraphPad Prism Version 4.00 for Windows (GraphPad 
Software Inc.).
3. Results 
  Twelve plant species: roots of Adenia gummifera (A. 
gummifera) (Harv.) Harms (Passifloraceae), Piper capense 
(P. capense) L.f. (Piperaceae); Zanthoxylum davyi (Z. davyi 
) (I. Verd.) P.G. Watermann (Rutaceae), Xysmalobium 
undulatum (X. undulatum) (L.)W.T.Aiton. (Apocynaceae), 
Lannea schweinfurthii (L. schweinfurthii) (Engl.) Engl. 
(Anacardiaceae), Terminalia sericea (T. sericea) Burch. ex 
DC. (Combretaceae), Ziziphus mucronata (Z. mucronata) 
Willd. (Rhamnaceae), Tabernaemontana elegans (T. 
elegans) Stapf. (Apocynaceae), Crinum bulbispermum 
(C. bulbispermum) (Burm.f.) Milne-Redh. & Schweick. 
(Amaryllidaceae), Scadoxus puniceus (S. puniceus) (L.) 
Friis & I. Nordal. (Amaryllidaceae), Tulbaghia violacea (T. 
violacea) Harv. (Alliaceae) and fruits of Ficus capensis (F. 
capensis) Thunb. (Moraceae) were investigated for AChEI as 
these plants have been reported to treat various neurological 
conditions[28-39]. Ten of the plant species showed some level 
of inhibitory activity against AChE as indicated by their IC50 
values (Table 1). At the highest concentration (0.125 mg/
ml), 40% showed good (>50% inhibition), 50% moderate 
(30-50% inhibition) and 10% low (<30% inhibition) AChE 
inhibition[40]. L. schweinfurthii and S. puniceus root extracts 
showed the lowest IC50 values for the ethyl acetate extracts 
while Z. davyi had the lowest IC50 value for the methanol 
extracts (Table 1). Generally, inhibition of AChE was dose 
dependent and the ethyl acetate extracts were more active 
than the methanol extracts.
  The ethyl acetate extracts of all the plants with the 
exception of T. sericea showed either no activity or very 
low radical scavenging activity in both the DPPH and ABTS 
assays as indicated by their IC50 values (Table 1). As the 
methanol extract showed higher activity, it would appear 
as if very polar solvents are able to extract compounds 
containing antioxidant activity. Methanol extracts of the 
roots of five plants and ethyl acetate of one plant showed 
radical scavenging activity < 50%.
  The extracts which showed good DPPH and ABTS radical 
scavenging ability (> 60%) were further evaluated for their 
phenolic composition (Table 2). The levels of these phenolic 
EA Adewusi et al./Asian Pacific Journal of Tropical Medicine (2011)829-835832
compounds are an indication of the potential antioxidant 
activity of the plant extracts. The methanol extracts of T. 
sericea roots contained the highest flavonoid and flavonol 
content. 
4. Discussion
  Z. davyi roots showed good AChEI with IC50 values of 
0.01 mg/mL and 0.012 mg/mL for the methanol and ethyl 
acetate extracts respectively. Seven benzo[c]phenanthridine 
alkaloids have been isolated from the stem-bark of Z. 
davyi[41], and these or similar alkaloids may be responsible 
for its observed inhibition of acetylcholinesterase. Also, 
anticonvulsant activity has been reported for both the 
methanol and aqueous leaf extracts of Z. capense[42]. As 
convulsion is a neurologic disorder, similar compounds 
present in the roots of Z. davyi may be responsible for 
its activity and this supports the traditional use of the 
plant in the treatment of neurologic diseases. Z. capense 
leaves have also been shown to contain triterpene steroids 
and saponins and these compounds are known to exhibit 
neuroprotective activity[43]. The ethyl acetate extracts of 
C. bulbispermum bulbs showed an IC50 value of 0.039 mg/
ml for AChEI, which may be ascribed to several alkaloids 
which have been isolated from the plant[44]. In addition 
alkaloidal extracts from Crinum jagus and C. glaucum 
have been demonstrated to possess AChEI activity which 
Table 1
AChEI, ABTS and DPPH radical scavenging activity of methanol and ethyl acetate extracts.
Species
Extraction solvent
(plant part)
AChE inhibition
IC50 (mg/mL)
ABTS radical inhibition
 IC50 (mg/mL)
DPPH radical inhibition
 IC50 (mg/mL)
A. gummifera  Ethyl acetate (root) 0.018 9依0.005 * *
P. capense Methanol (root) * 0.040 2依0.003 0.044 3依0.010
Ethyl acetate (root) 0.040 7依0.012 * *
Z. davyi Methanol (root) 0.010 0依0.004 0.075 2依0.021 *
Ethyl acetate (root) 0.011 6依0.002 * *
X. undulatum Ethyl acetate (root) 0.000 5依0.000 * *
L. schweinfurthii Methanol (root) * 0.003 6依0.001 0.015 1依0.004
Ethyl acetate (root) 0.000 3依0.000 * *
T. sericea Methanol (root) * 0.003 1依0.001 0.014 7依0.006
Ethyl acetate (root) * 0.074 6依0.017 *
Z. mucronata Methanol (root) * 0.018 7依0.020 0.029 1依0.051
Ethyl acetate (root) 0.011 2依0.003 * *
F. capensis Ethyl acetate (fruit) 0.031 9依0.005 * *
S. puniceus Ethyl acetate (bulb) 0.000 3依0.000 * *
C. bulbispermum Ethyl acetate (root) 0.039 3依0.014 * *
Methanol (bulb) 0.014 8依0.039 0.068 5依0.041 *
Ethyl acetate (bulb) 0.002 1依0.007 * *
Galanthamine N/A 5.3伊10-5 N/A N/A
Trolox N/A N/A 0.013 1 9.6伊10-6
*Represents extracts with maximum inhibition below 50% at the highest tested concentration of 0.125 mg/mL.
Table 2
Total phenol, flavonoid and flavonol contents of the methanolic plant extracts with antioxidant activity (> 60%).
Plant and part Total phenola Total flavonoidb Total flavonolb
Z. davyi roots   97.26依0.40    8.66依0.40 22.84依0.10
L. schweinfurthii roots 101.27依0.10  13.58依0.30 17.29依0.60
T. sericea roots   36.73依0.21  73.05依0.40 28.78依0.50
Z. mucronata roots   73.86依0.25  17.76依0.20 15.53依0.30
C. bulbispermum roots 202.38依0.50    9.18依0.50 20.79依0.10
P.  capense roots 237.60依0.12  18.14依0.20 12.90依0.10
aExpressed as mg tannic acid/g of extract. bExpressed as mg quercetin/g of extract.
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has been ascribed to hamayne (IC50-250 毺mol/L) and 
lycorine (IC50-450 毺mol/L)[45]. Furthermore, the alkaloids; 
haemanthamine and lycorine, isolated from C. ornatum, 
have been shown to contain anticonvulsant activity[46]. It is 
possible that the presence of these or similar alkaloids may 
be responsible for the activity observed. The ethyl acetate 
extract of Piper capense was observed to show inhibition of 
AChEI with an IC50 value of 0.041 mg/mL. Amide alkaloids 
with activity in the CNS have been identified from the roots 
of P. guineense[28]. P. methysticum has been reported to 
possess local anaesthetic, sedating, anticonvulsive, muscle-
relaxant and sleep-stimulating effects which are due to 
the presence of kavopyrones[28]. P. capense contains the 
amide alkaloids; piperine and 4,5-dihydropiperine, which 
have previously been shown to have CNS activity[47]. Also, 
piperine has been reported to improve memory impairment 
and neurodegeneration in the hippocampus of animal 
models with AD[48]. The ethanol extracts of X. undulatum 
were found to exhibit good antidepressant-like effects 
in three animal models[49]. The leaves of this plant have 
also been reported to have good selective serotonin re-
uptake inhibitory activity[50]. The neuroprotective effect 
of the plant has been ascribed to several glycosides[29], 
which may be responsible for its observed activity as its 
ethyl acetate extracts showed inhibition of the enzyme with 
IC50 value of 0.000 5 mg/mL. Glycosides are among the 
class of compounds which show neuroprotective activity. 
Four pregnane glycosides; cynatroside A, cynatroside B, 
cynatroside C and cynascyroside D, have been isolated from 
C. atratum[51-53]. These glycosides showed AChE inhibition 
with IC50 values varying between 3.6 μmol/L for cynatroside 
B and 152.9 毺mol/L for cynascyroside D[51-53]. 
  Polar solvents have been reported to extract compounds 
including alkaloids which show cholinesterase inhibitory 
activity[22]. This explains the use of methanol and ethyl 
acetate as solvents for extraction in this study. As the ethyl 
acetate extracts showed better activity for most of the plants, 
it may appear as if the solvent is able to extract more of the 
compounds which inhibit AChE.
  Several Anacardiaceae species including Lannea 
velutina, Sclerocarya birrea and Harpephyllum caffrum 
have been shown to be a source of natural antioxidants. 
This activity has been ascribed to the high levels of 
proanthocyanidins and gallotannins present in the plants[54]. 
As L. schweinfurthii, belongs to the same family, similar 
compounds could be present and therefore responsible 
for its good antioxidant activity, as its methanol extracts 
showed an IC50 value of 0.003 6 mg/mL for inhibition of ABTS 
radicals. P. capense showed good antioxidant activity (IC50 
value of 0.040 2 mg/mL and 0.044 3 mg/mL for inhibition of 
ABTS and DPPH radicals) which has also been reported for 
other Piper species; P. arboreum and P. tuberculatum[55-57]. 
This activity has been ascribed to the flavonols; quercetin 
and quercitrin[58]. The leaves and roots of T. sericea 
are reported to be used traditionally in treating several 
infections and diseases. Sericoside, the triterpenoidal 
saponin found in T. sericea has been reported to have anti-
inflammatory and antioxidant activity[59]. Sericoside acts by 
reducing neutrophil infiltration and decreasing superoxide 
generation due to its radical scavenging activity[60] and it 
may be responsible for the antioxidant activity of the plant 
as observed in the study. C. ornatum bulbs have been shown 
to contain good inhibition of DPPH radicals and hydrogen 
peroxide as well as being able to inhibit peroxidation of 
tissue lipids in the malonaldehyde test[30]. Similar to the 
AChEI activity, lycorine and haemanthamine have been 
reported to be responsible for the antioxidant activity[46]. 
  The total phenolic content of the methanol extracts of P. 
capense and C. bulbispermum roots were relatively high for 
both solvents tested. Phenolic compounds contribute to the 
antioxidant activity of plant extracts and they are well known 
as radical scavengers, metal chelators, reducing agents, 
hydrogen donors and singlet oxygen quenchers[60].
  Flavonoids have been reported to be partly responsible for 
antioxidant activity, as they act on enzymes and pathways 
involved in anti-inflammatory processes[61]. Furthermore, 
the hydrogen-donating substituents (hydroxyl groups) 
attached to the aromatic ring structures of flavonoids enable 
them to undergo a redox reaction, which in turn, helps them 
scavenge free radicals[62].
  Flavonols are phytochemical compounds found in high 
concentrations in a variety of plant-based foods and 
beverages[58]. Consumption of flavonols has been associated 
with a variety of beneficial effects including an increase 
in erythrocyte superoxide dismutase activity, decrease in 
lymphocyte DNA damage, decrease in urinary 8-hydroxy-
2´-deoxyguanosine, and an increase in plasma antioxidant 
capacity[58].
  The roots of P. capense, Z. capense, L. schweinfurthii, 
Z. mucronata and C. bulbispermum  showed good 
antioxidant and cholinesterase inhibitory activity. These 
findings support the traditional use of the plants for 
treating neurological disorders especially those where a 
cholinesterase mechanism and reactive oxygen species are 
involved. These novel leads require further investigation.
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